News & Events
Stay informed about news and conference activities from Secant Group.
News
- John Witkowski Appointed President & CEO of Solesis
- Solesis to Open First Manufacturing Site in Costa Rica Dedicated to Custom Polymer and Textile Healthcare Solutions
- Edwards Lifesciences Awards Secant Group 2022 Supplier of the Year
- Solesis Expands Film & Coating Capabilities with Acquisition of Polyzen
- Secant Group, Nationwide Children’s Hospital Collaborate to Advance Breakthrough Cardiovascular Technology
Recent Conference Activities
Anaheim Convention Center
Anaheim, California
February 6-8, 2024
(Exhibiting with Polyzen)
Booth #3171
Hybrid (In Person/Online)
San Francisco, California
August 13-17, 2023
Oral Presentations:
“Developing a biodegradable polyurethane platform for varying therapeutic time frames.”
Biomaterials and Biointerfaces Symposium
Presenter: Mohamed Elkhodiry, PhD, Engineer II, Secant Group
Date/Location: August 15, 3:50pm – 4:10pm PT (Rm. 310, South Building/Moscone Center)
“Poly(glycerol ester)-based polyplex nanoparticles for safe and effective gene delivery.”
General Topics: New Synthesis and Characterization of Polymers Symposium
Presenter: Scott Radzinski, PhD, Staff Scientist, Secant Group
Date/Location: August 16, 5:00pm – 5:20pm PT (Salon 6, San Francisco Marriott Marquis)
Poster Presentations:
“Investigating hydrophobic and hydrophilic polyglycerol esters for non-viral delivery.”
(Poster #2760).
General Topics: New Synthesis and Characterization of Polymers Symposium
Presenter: Caroline Costello, Associate Scientist, Secant Group
Date/Location: August 15, 7:00pm – 9:00pm PT (Hall F, South Building/Moscone Center)
“Polyester-based non-viral vectors for gene therapy: Characterization and optimization of poly(glycerol ester) polymers.”
(Poster #2762).
General Topics: New Synthesis and Characterization of Polymers Symposium)
Presenter: Benjamin Roadarmel, Scientist, Secant Group
Date/Location: August 15, 7:00pm – 9:00pm PT (Hall F, South Building/Moscone Center)
Roadmapping the Clinical and Regulatory Paths of Subcutaneous Products and Technologies
Virtual Workshop
Feb. 23, 2023
“High Dose Payload Delivery Using Bioerodible Subcutaneous Implants”
Presenter: Stephanie Reed, PhD; Director, Translational Product Development, Secant Group
Anaheim Convention Center
Anaheim, CA
Feb. 7-9, 2023
Booth #3255 (Exhibiting with Polyzen)
American Association of Pharmaceutical Scientists (AAPS) 2022 PharmSci 360
Boston Convention & Exhibition Center
Boston, MA
Oct. 16-19, 2022
- Expandable Single-Component Gastroretention Devices: Shape Optimization & Proof of Concept for Extended Gastric Residency and Drug Release In Vivo Presenter: Alexander Stahl, PhD; Scientist II, Secant Group
- Drug-loaded Hydralese™ Poly(Glycerol Sebacate) Urethane Elastomers as Intra-vitreal Microdevices for Ocular Drug Delivery Applications Presenter: Stephanie Reed, PhD; Director, Translational Product Development, Secant Group
- Small-Scale, Rapid Prototyping of Hydralese™ (PGSU) (poly(glycerol sebacate) urethane) Microdevices for Controlled Drug Delivery in Ocular Implants Presenter: Dennis Carney, Senior Engineer, Secant Group